Directorate change

Summary by AI BETAClose X

Aquila European Renewables PLC has appointed Christopher Mills as a Non-Executive Director, effective May 21, 2026, bringing extensive experience from founding Harwood Capital Management and his current role with North Atlantic Smaller Companies Investment Trust plc. Concurrently, Non-Executive Director Myrtle Dawes intends to step down at the 2026 Annual General Meeting as the company progresses its managed wind-down. Mr. Mills, who is co-manager of Achilles Investment Company Limited holding 5,110,000 ordinary shares, will donate his director fees to the Harwood Charitable Trust.

Disclaimer*

Aquila European Renewables PLC
21 May 2026
 

21 May 2026

 

Aquila European Renewables plc

 

Director Change

 

Aquila European Renewables plc ("AERI" or the "Company") announces the appointment of Christopher Mills as a Non-Executive Director with effect from 21 May 2026.

 

Mr Mills founded Harwood Capital Management in 2011, a successor to its former parent company JO Hambro Capital Management, which he co-founded in 1993 and of which he was formerly the Chief Investment Officer. He is currently the Chief Executive Officer and Investment Manager of North Atlantic Smaller Companies Investment Trust plc, a UK listed investment trust, and a Non-Executive Director of several companies.

 

Mr Mills has indicated that he will donate his director fees received from the Company to the Harwood Charitable Trust, which provides educational support, mainly for doctors in Africa.

 

As the Company enters the next stage of its managed wind down, Myrtle Dawes, Non-Executive director, has stated her intention to step down from the Board at the 2026 Annual General Meeting.

Robert Naylor, Non-Executive Chair of the Board of the Company, said:

 

"On behalf of the Board, I would like to thank Myrtle for her valuable contribution to the Company.

 

We are pleased to welcome Christopher Mills to the Board. His expertise and insight will be invaluable as we continue our engagement with Aquila Capital, a wholly owned subsidiary of Commerzbank, the Company's investment adviser"

 

As at the date of this announcement, Mr Mills is co-manager on Achilles Investment Company Limited which hold 5,110,000 ordinary shares in the Company.

 

The following information is disclosed in accordance with UK Listing Rule 6.4.8 in connection with the appointment of Mr Mills to the Board of the Company:

 

Current Directorships*

Previous Directorships in the past five years*

Assetco plc
Bigblu Broadband plc
Catalyst Media Group plc
EKF Diagnostics Holdings plc

Elementis plc

Frenkel Topping Group plc
MJ Gleeson Plc
North Atlantic Smaller Companies Investment Trust plc
Oryx International Growth Fund Limited
Renalytix plc

Augean plc
Curtis Banks Group Limited
Gabelli Value Plus+ Trust plc
Goals Soccer Centres plc
Sunlink Health Systems Inc
Ten Entertainment Group plc
Trellus Health plc
Sureserve Group plc
Hipgnosis Songs Fund Limited

The PRS REIT plc

 

 

*other publicly quoted companies only

 

There are no additional matters that would require disclosure under UKLR 6.4.8 in respect of Mr Mills.

 

LEI: 213800UKH1TZIC9ZRP41

 

Enquiries:

Apex Listed Companies Services (UK) Limited (Company Secretary)

 

+44 (0) 20 3327 9720

Deutsche Numis (Corporate Broker)

Hugh Jonathan             

George Shiel

 

+44 (0) 20 7260 1000

www.aquila-european-renewables.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings